key: cord-0975639-j1hsf4l0
authors: Sardari, Akram; Tabarsi, Payam; Borhany, Hamed; Mohiaddin, Raad; Houshmand, Golnaz
title: Myocarditis detected after COVID-19 recovery
date: 2020-05-27
journal: Eur Heart J Cardiovasc Imaging
DOI: 10.1093/ehjci/jeaa166
sha: 57bb2353a127c825ab8ccca5e3d66ed785bf8a73
doc_id: 975639
cord_uid: j1hsf4l0

nan

A 31-year-old internal medicine registrar presented with dyspnoea on exertion and low-grade fever. He had a history of COVID-19 pneumonia and was discharged 3 weeks previously. He did not have any other specific past medical history. At his previous admission, RT-PCR was positive for SARS-CoV-2, lung CT (Panel A) showed bilateral ground-glass and consolidative opacities mostly in the right lower zone, and the laboratory data showed high C-reactive protein (CRP) levels of 105 mg/L and erythrocyte sedimentation rate (ESR) of 70 mm/h but normal high sensitivity troponin T of <0.03 ng/mL. In the second week, he experienced pleuritic chest pain with no ECG changes. Troponin was not checked at that time. He was discharged after 10 days with two subsequent negative RT-PCRs and in good condition. CT at discharge (Panel B) showed significant resolution of consolidation with bilateral multifocal ground-glass appearance.

Three weeks after discharge, he presented with dyspnoea on exertion and low-grade fever. On examination, he had a blood pressure of 110/80 mmHg, respiratory rate 18 breaths/ min, heart rate 70 b.p.m., temperature 37.8 C (axillary), and O 2 Sat 96%. Blood cell count (CBC) was normal, CRP was 3.3 mg/L, and high sensitivity troponin T was <0.03 ng/mL. RT-PCR was negative for SARS-CoV-2. A 12-lead electrocardiogram was normal. The transthoracic echocardiography had a poor acoustic window but

Late gadolinium enhancement (Panel E and F) showed subepicardial fibrosis in the mid inferior wall. The clinical and imaging features were suggestive for active myocarditis. The patient was clinically stable with no arrhythmia or signs of heart failure, so we did not perform an endomyocardial biopsy. Other serological tests for Coxsackie, Parvovirus B19, Epstein-Barr, and human herpesvirus were negative. The myocarditis could be residual myocardial inflammation as a result of COVID-19, and the cardiac involvement might be overlooked during pneumonia. Medical treatment was started with bisoprolol and lisinopril